Organon & Co. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1289534,
    "name": "Organon & Co.",
    "stock_name": "Organon & Co.",
    "full_name": "Organon & Co.",
    "name_url": "stocks-analysis/organon-co",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.84",
    "chg": -0.15,
    "chgp": "-2.15%",
    "dir": -1,
    "prev_price": "6.99",
    "mcapval": "2,721.84",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US68622V1061",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "9.46 M",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/organon-co-1289534-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Organon & Co. Stock Plummets to New 52-Week Low of $6.18",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/organon-co-stock-plummets-to-new-52-week-low-of-618-3662036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/OrganonCo_priceRelatedfactors_3662036.png",
        "date": "2025-10-31 16:30:34",
        "description": "Organon & Co. has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has a market capitalization of USD 2,722 million, a low P/E ratio, and a high return on equity, but faces operational difficulties and increased costs."
      },
      {
        "title": "Organon & Co. Hits New 52-Week Low at USD 6.32 Amid Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/organon-co-hits-new-52-week-low-at-usd-632-amid-decline-3659214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/OrganonCo_priceRelatedfactors_3659214.png",
        "date": "2025-10-30 18:53:36",
        "description": "Organon & Co. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has a market capitalization of USD 2,722 million, a low P/E ratio, and reports a decrease in net profit alongside rising raw material costs, indicating ongoing financial struggles."
      },
      {
        "title": "Organon & Co. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/organon-co-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-stock-volatility-3559658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/OrganonCo_technicaldot_3559658.png",
        "date": "2025-09-23 16:28:53",
        "description": "Organon & Co., a small-cap pharmaceutical company, is experiencing stock price fluctuations, currently at $10.57. The company has faced significant challenges, with a year-over-year return of -45.77%, underperforming the S&P 500. Technical indicators present a mixed outlook, reflecting varied momentum in the market."
      },
      {
        "title": "Is Organon & Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-organon-co-technically-bullish-or-bearish-3558479",
        "imagepath": "",
        "date": "2025-09-23 11:22:36",
        "description": "As of 19 September 2025, the technical trend for Organon & Co. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish trend, alongside the monthly MACD and KST both showing bearish signals. The weekly Bollinger Bands are bullish, but this is offset by the overall bearish indicators on the monthly timeframe. \n\nIn terms of performance, Organon has underperformed the S&P 500 significantly over the year, with a return of -45.77% compared to the S&P 500's 16.64%...."
      },
      {
        "title": "Is Organon & Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-organon-co-technically-bullish-or-bearish-3552338",
        "imagepath": "",
        "date": "2025-09-22 18:08:27",
        "description": "As of 19 September 2025, the technical trend for Organon & Co. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are mildly bearish, while the Bollinger Bands show a mildly bullish stance on the weekly and mildly bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly. Overall, the Dow Theory and OBV are both mildly bullish on the weekly and monthly time frames.\n\nIn terms of performance, Organon has underperformed the S&P 500 across multiple periods, with a year-to-date return of -29.96% compared to the S&P 500's 13.31%, and a one-year return of -48.22% versus 16.64% for the index. This indicates significant weakness relative to the benchmark...."
      }
    ],
    "total": 11,
    "sid": "1289534",
    "stock_news_url": "https://www.marketsmojo.com/news/organon-co-1289534"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Organon & Co. Stock Plummets to New 52-Week Low of $6.18

2025-10-31 16:30:34

Organon & Co. has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has a market capitalization of USD 2,722 million, a low P/E ratio, and a high return on equity, but faces operational difficulties and increased costs.

Organon & Co. Hits New 52-Week Low at USD 6.32 Amid Decline

2025-10-30 18:53:36

Organon & Co. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company has a market capitalization of USD 2,722 million, a low P/E ratio, and reports a decrease in net profit alongside rising raw material costs, indicating ongoing financial struggles.

Organon & Co. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-09-23 16:28:53

Organon & Co., a small-cap pharmaceutical company, is experiencing stock price fluctuations, currently at $10.57. The company has faced significant challenges, with a year-over-year return of -45.77%, underperforming the S&P 500. Technical indicators present a mixed outlook, reflecting varied momentum in the market.

Is Organon & Co. technically bullish or bearish?

2025-09-23 11:22:36

As of 19 September 2025, the technical trend for Organon & Co. has changed from sideways to mildly bearish. The current stance is bearish, primarily driven by the daily moving averages indicating a mildly bearish trend, alongside the monthly MACD and KST both showing bearish signals. The weekly Bollinger Bands are bullish, but this is offset by the overall bearish indicators on the monthly timeframe. In terms of performance, Organon has underperformed the S&P 500 significantly over the year, with a return of -45.77% compared to the S&P 500's 16.64%....

Is Organon & Co. technically bullish or bearish?

2025-09-22 18:08:27

As of 19 September 2025, the technical trend for Organon & Co. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the monthly MACD is bearish, indicating mixed signals. The daily moving averages are mildly bearish, while the Bollinger Bands show a mildly bullish stance on the weekly and mildly bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly. Overall, the Dow Theory and OBV are both mildly bullish on the weekly and monthly time frames. In terms of performance, Organon has underperformed the S&P 500 across multiple periods, with a year-to-date return of -29.96% compared to the S&P 500's 13.31%, and a one-year return of -48.22% versus 16.64% for the index. This indicates significant weakness relative to the benchmark....

View All News